Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA vaccination

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 2122-2132

  Tisch, R ^a   Wang, B ^a   Weaver, D J ^a   Liu, B ^a   Bui, T ^a   Arthos, J ^a   Serreze, D V ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 4; LYSOZYME; PLASMID DNA; RECOMBINANT DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; FEMALE; GENETIC ENGINEERING; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TH2 CELL; VACCINATION;

EID: 0035253510     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.2122     Document Type: Article

References (43)

1. Insulin-dependent diabetes mellitus as an autoimmune disease
2. Type-1 diabetes: A chronic autoimmune disease of human, mouse, and rat
3. Insulin dependent diabetes mellitus
4. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
5. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
6. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
7. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells
8. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
9. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes
10. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
11. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
12. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation?
13. Cytokines induce the development of functionally heterogeneous T helper cell subsets
14. + T cell responses: The alternative approaches
15. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
16. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
17. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
18. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
19. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription
20. Antigen-specific immunotherapy: Is it a real possibility to combat T-cell-mediated autoimmunity?
21. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
22. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice
23. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
24. DNA vaccines
25. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
26. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
27. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
28. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity
29. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T cell costimulation
30. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fe of immunoglobulin G suppresses experimental autoimmune encephalomyelitis
31. Simian immunodeficiency vires-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys
32. + T cells in initiation of insulin dependent diabetes mellitus
33. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice
34. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice
35. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes
36. Ontogeny of T cell tolerance to peripherally expressed antigens
37. Generation and analysis of interleukin-4 deficient mice
38. Interleukin-4 deficiency does not exacerbate disease in NOD mice
39. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization
40. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
41. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
42. DNA immunization to prevent autoimmune diabetes
43. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice